Drreddys Laboratories | RDY - L'Utile Operativo





L'Utile Operativo Cambiamento Data
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Aurora Cannabis CAD -55.67M 35.45M 2025-09
Bayer EUR 1.11B 1.65B 2025-12
Canopy Growth CAD -14.3M 3.18M 2025-09
Cipla INR 9.77B 6.21B 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Drreddys Laboratories INR 14.33B 2.51B 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Hikma Pharmaceutical USD 348M 161M 2025-12
Lonza CHF 430M 104M 2024-12
Novartis USD 4.5B 363M 2025-09
Pacira USD 3.19M 9.96M 2025-12
Phibro Animal Health USD 25.53M 7.83M 2024-12
Prestige Brands USD 82.49M 2.82M 2025-12
Richter Gedeon HUF 63.58B 132M 2025-09
Sun Pharmaceuticals INR 33.67B 49.9M 2025-09
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12